Acrometa Group Signs MOU for Sand Concession, Opening New Business Opportunities in the Region Nov 06, 2023 21:00 HKT/SGT Read More
DC Healthcare Unveils Innovative Skincare Range 'newB' Under Subsidiary Ten Doctors Sdn Bhd Nov 01, 2023 19:00 HKT/SGT Read More
Acrometa to Focus on Laboratory Construction and Co-Working Laboratory Space Business Oct 31, 2023 21:00 HKT/SGT Read More
EW Healthcare Partners Acquires Stake in Boiron Group, a Leader in Natural Medicine Oct 27, 2023 21:00 HKT/SGT Read More
LEQEMBI (lecanemab-Irmb) Named One of Time's Best Inventions of 2023 Oct 25, 2023 19:43 HKT/SGT Read More
四环医药(0460.HK)旗下轩竹生物自主研发吡罗西尼单药II期试验入选2023 ESMO 为晚期HR+/HER2-乳腺癌患者提供了新思路 Oct 24, 2023 10:50 HKT/SGT Read More
아방스 클리니컬, 45개의 한국 생명 공학 기업 초청해 한국과 호주에서 미국으로 이어지는 글로벌레디 신약 개발 경로에 대한 설명회 개최 Oct 19, 2023 18:00 HKT/SGT Read More
Avance Clinical Invited to Brief 45 Korean Biotechs on Their GlobalReady Drug Development Pathway from Korea and Australia to the US Oct 19, 2023 09:00 HKT/SGT Read More
Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical: The NDA of the New Drug, independently developed for the treatment of advanced breast cancer was accepted by NMPA Oct 17, 2023 16:01 HKT/SGT Read More
Eisai to Present New Data from LEQEMBI (Lecanemab-Irmb) Phase 3 Clarity Ad Study and Other Alzheimer's Disease Pipeline Research at The Clinical Trials on Alzheimer's Disease (CTAD) Conference Oct 16, 2023 13:07 HKT/SGT Read More
エーザイ、第16回アルツハイマー病臨床試験会議(CTAD)において「レケンビ」の臨床第III相Clarity AD試験の新規データを含むアルツハイマー病領域の最新データを発表 Oct 16, 2023 11:00 JST Read More